Davercin (Erythromycin cyclocarbonate), an Erythromycin derivative, is a potent bacteriostatic antibiotic macrolide produced by Streptomyces erythreus and is active against Gram-positive and some Gram-negative microorganisms.

Thiostrepton is thiazole-based cyclic peptide isolated from Streptomyces and is active against gram-positive bacteria.

Cadazolid, also known ACT-179811, is a novel fluoroquinolone-oxazolidinone antibiotic and a protein synthesis inhibitor.

Relebactam (also known as MK7655; MK-7655) is a diazabicyclooctane that acts as a potent and selective β-lactamase inhibitor.

Carbenicillin Disodium is a broad-spectrum, parenterally-administered, semisynthetic and bactericidal antibiotic belonging to the carboxypenicillin subgroup of the penicillins.

PK150 (PK-150; PK 150), a Sorafenib analog, is an oral bioavailable antibacterial agent with activity against pathogenic strains at submicromolar concentrations.

Gemifloxacin mesylate (LB-20304; SB-265805; LB20304; SB265805; Factive), the mesylate salt of Gemifloxacin, is a third generation, orally bioavailable, broad-spectrum quinolone antibacterial agent, used in the treatment of acute bacterial exacerbation of chronic bronchitis, and mild-to-moderate pneumonia.

Nithiamide (NSC-45914) is a novel and potent Antibacterial drug used as a veterinary medicine.

MAC-545496 is novel and potent inhibitor of GraR (glycopeptide-resistance-associated protein R) with nanomolar activity.

Temafloxacin (Omniflox) is a potent fluoroquinolone antibiotic and antimycobacterial agent that acts as a DNA topoisomerase inhibitor.